Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-27

Clinical Trial Update: Antioxidation Medication for Noise-induced Hearing Loss [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of an antioxidation medication for noise-induced hearing loss has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hearing Loss | Phase 2 | Status: COMPLETED | Results posted: 2010-07-27